Online Program

295528
Delivering Oral Cholera Vaccination in Haiti: The first 100,000 doses


Monday, November 4, 2013 : 11:15 a.m. - 11:30 a.m.

Louise C Ivers, MD MPH, Partners in Health/ Harvard Medical School, Boston, MA
A cholera epidemic has claimed the lives of over 8,000 Haitians and sickened 650,000 since the outbreak began in October 2010. Early intervention in the epidemic focused on case-finding, treatment, and water and sanitation interventions for prevention of transmission. In December 2011, the Minister of Health of Haiti called for a demonstration of the acceptability and feasibility of the use of OCV in urban and rural Haiti. This presentation describes the department of rural Haiti and a second region in urban Port-au-Prince in addition to other ongoing treatment and control measures. Despite logistics and cold chain challenges, 100,00 individuals were successfully vaccinated with OCV in the region, with 90.8% of those completing their second dose.

Learning Areas:

Protection of the public in relation to communicable diseases including prevention or control

Learning Objectives:
Describe the successes and challenges of the use of oral cholera vaccine in an epidemic setting.

Keyword(s): Communicable Disease, Prevention

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am qualified to give this presentation because I am infectious disease specialist that led the introduction of oral cholera vaccine to Haiti.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.